{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Asialoglycoprotein receptors", "Chitosan", "Chondroitin sulfate", "Hepatocellular carcinoma", "Intracellular targeting", "Oral bioavailability", "Polymeric nanoparticles", "Simvastatin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33424274", "DateRevised": {"Year": "2021", "Month": "01", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jsps.2020.11.012"], "Journal": {"ISSN": "1319-0164", "JournalIssue": {"Volume": "28", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society", "ISOAbbreviation": "Saudi Pharm J"}, "ArticleTitle": "Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability.", "Pagination": {"StartPage": "1851", "EndPage": "1867", "MedlinePgn": "1851-1867"}, "Abstract": {"AbstractText": ["Simvastatin (SV) repurposing has emerged as an alternative approach for the treatment of cancer. In this study, SV chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate (SVCSChSNPs) were developed in order to maximize SV therapeutic efficiency. The hepatic targeting was realized using N-acetylgalactosamine (GalNAc) residues of ChS, which can be identified by the ASGPR receptors specifically expressed in hepatocytes. SV was repurposed as an anticancer agent against hepatocellular carcinoma (HCC). NPs were fabricated by the ionic gelation method, and the formulation variables (CS concentration, CS:ChS ratio, and CS solution pH) were optimized using a three-factor, three-level Box-Behnken design. The optimized NPs were investigated for particle size, size distribution, zeta potential, morphology, <i>in vitro</i> cytotoxicity, apoptotic effects against human hepatocellular carcinoma HepG2 cells, and detection of intracellular localization. The NPs were further evaluated for <i>in vitro</i> release behavior of SV and pharmacokinetics using Wister albino rats. Transmission electron microscopy (TEM) imaging showed a spherical shape with regular surface NPs of\u00a0<\u00a0100\u00a0nm diameter. In vitro cytotoxicity testing showed that the SVCSChSNPs exhibited greater inhibition of proliferation in HepG2 cells and high cellular uptake through ASGPR-mediated endocytosis. The <i>in vitro</i> dissolution profile was 2.1-fold greater than that of pure SV suspension. Furthermore, <i>in vivo</i> oral pharmacokinetics revealed that the obtained NPs enhanced the bioavailability of SV by up to 2- and 1.6-fold for SV and SVA, respectively, compared to the pure SV suspension. These findings demonstrated that hepatic-targeted CSChSNPs delivering SV could potentially serve as a promising platform for HCC and other liver-related diseases."], "CopyrightInformation": "\u00a9 2020 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Cairo, Egypt."}, {"Identifier": [], "Affiliation": "Kayyali Chair for Pharmaceutical Industry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Faris", "ForeName": "Tarek M", "Initials": "TM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kayyali Chair for Pharmaceutical Industry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, College of Pharmacy, Al-Azhar University, Cairo, Egypt."}], "LastName": "Harisa", "ForeName": "Gamaleldin I", "Initials": "GI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kayyali Chair for Pharmaceutical Industry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alanazi", "ForeName": "Fars K", "Initials": "FK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Cairo, Egypt."}], "LastName": "Samy", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic, and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Saudi Arabia."}], "LastName": "Nasr", "ForeName": "Fahd A", "Initials": "FA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi Pharm J", "NlmUniqueID": "9705695", "ISSNLinking": "1319-0164"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdullah T.A., Ibrahim N.J., Warsi M.H. Int. J. Pharm. Investig.; 2016. Chondroitin Sulfate-chitosan Nanoparticles for Ocular Delivery of Bromfenac Sodium: Improved Permeation, Retention, and Penetration; p. 6.", "ArticleIdList": ["PMC4797493", "27051629"]}, {"Citation": "Ahmed O.A.A., Hosny K.M., Al-Sawahli M.M., Fahmy U.A. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des. Devel. Ther. 2015;9:655\u2013662. doi: 10.2147/DDDT.S76194.", "ArticleIdList": ["10.2147/DDDT.S76194", "PMC4315536", "25670883"]}, {"Citation": "Alkhatib M.H., Al-Merabi S.S. In vitro assessment of the anticancer activity of simvastatin-loaded microemulsion in liver and colon cancer cells. J. Drug Deliv. Sci. Technol. 2014;24:373\u2013379. doi: 10.1016/S1773-2247(14)50076-7.", "ArticleIdList": ["10.1016/S1773-2247(14)50076-7"]}, {"Citation": "Barclay T.G., Day C.M., Petrovsky N., Garg S. Review of polysaccharide particle-based functional drug delivery. Carbohydr. Polym. 2019;221:94\u2013112. doi: 10.1016/j.carbpol.2019.05.067.", "ArticleIdList": ["10.1016/j.carbpol.2019.05.067", "PMC6626612", "31227171"]}, {"Citation": "Bradbury P., Traini D., Ammit A.J., Young P.M., Ong H.X. Repurposing of statins via inhalation to treat lung inflammatory conditions. Adv. Drug Deliv. Rev. 2018;133:93\u2013106. doi: 10.1016/j.addr.2018.06.005.", "ArticleIdList": ["10.1016/j.addr.2018.06.005", "29890243"]}, {"Citation": "Bugnicourt L., Ladavi\u00e8re C. Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications. Prog. Polym. Sci. 2016;60:1\u201317. doi: 10.1016/j.progpolymsci.2016.06.002.", "ArticleIdList": ["10.1016/j.progpolymsci.2016.06.002"]}, {"Citation": "Calvo P., Remu\u00f1\u00e1n-L\u00f3pez C., Vila-Jato J.L., Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 1997;63:125\u2013132. doi: 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4.", "ArticleIdList": ["10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4"]}, {"Citation": "Cho S.-J., Kim J.S., Kim J.M., Lee J.Y., Jung H.C., Song I.S. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int. J. Cancer. 2008;123:951\u2013957. doi: 10.1002/ijc.23593.", "ArticleIdList": ["10.1002/ijc.23593", "18521906"]}, {"Citation": "D\u2019Souza A.A., Devarajan P.V. Asialoglycoprotein receptor mediated hepatocyte targeting \u2014 Strategies and applications. J. Control. Release. 2015;203:126\u2013139. doi: 10.1016/j.jconrel.2015.02.022.", "ArticleIdList": ["10.1016/j.jconrel.2015.02.022", "25701309"]}, {"Citation": "Fan W., Yan W., Xu Z., Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surfaces B Biointerfaces. 2012;90:21\u201327. doi: 10.1016/j.colsurfb.2011.09.042.", "ArticleIdList": ["10.1016/j.colsurfb.2011.09.042", "22014934"]}, {"Citation": "Faris T., Harisa G.I., Alanazi F.K., Badran M.M., Alotaibi A.M., Alotaibi H., Alqahtani A.S., Samy A.M. Cytotoxicity of chitosan ultrafine nanoshuttles on the MCF-7 cell line as a surrogate model for breast cancer. Curr. Drug Deliv. 2020;17 doi: 10.2174/1567201817666200719005440.", "ArticleIdList": ["10.2174/1567201817666200719005440", "32682379"]}, {"Citation": "Fatehi Hassanabad A. Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms. Transl. lung cancer Res. 2019;8:692\u2013699. doi: 10.21037/tlcr.2019.09.08.", "ArticleIdList": ["10.21037/tlcr.2019.09.08", "PMC6835101", "31737505"]}, {"Citation": "Geboers S., Stappaerts J., Tack J., Annaert P., Augustijns P. In vitro and in vivo investigation of the gastrointestinal behavior of simvastatin. Int. J. Pharm. 2016;510:296\u2013303. doi: 10.1016/j.ijpharm.2016.06.048.", "ArticleIdList": ["10.1016/j.ijpharm.2016.06.048", "27340029"]}, {"Citation": "George A., Shah P.A., Shrivastav P.S. Natural biodegradable polymers based nano-formulations for drug delivery: A review. Int. J. Pharm. 2019;561:244\u2013264. doi: 10.1016/j.ijpharm.2019.03.011.", "ArticleIdList": ["10.1016/j.ijpharm.2019.03.011", "30851391"]}, {"Citation": "Harisa G.I., Alomrani A.H., Badran M.M. Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats. Eur. J. Pharm. Sci. 2017;96:62\u201371. doi: 10.1016/j.ejps.2016.09.004.", "ArticleIdList": ["10.1016/j.ejps.2016.09.004", "27613383"]}, {"Citation": "Harisa G.I., Badran M.M., AlQahtani S.A., Alanazi F.K., Attia S.M. Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi Pharm. J. 2016;24:74\u201381. doi: 10.1016/j.jsps.2015.03.024.", "ArticleIdList": ["10.1016/j.jsps.2015.03.024", "PMC4720020", "26903771"]}, {"Citation": "Harisa G.I., Faris T.M. Direct drug targeting into intracellular compartments: Issues, limitations, and future outlook. J Membr. Biol. 2019;252:527\u2013539. doi: 10.1007/s00232-019-00082-5.", "ArticleIdList": ["10.1007/s00232-019-00082-5", "31375855"]}, {"Citation": "Hejjaji E.M.A., Smith A.M., Morris G.A. Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios. Int. J. Biol. Macromol. 2018;120:1610\u20131617. doi: 10.1016/j.ijbiomac.2018.09.185.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.09.185", "30282010"]}, {"Citation": "Hu C.-S., Tang S.-L., Chiang C.-H., Hosseinkhani H., Hong P.-D., Yeh M.-K. Characterization and anti-tumor effects of chondroitin sulfate\u2013chitosan nanoparticles delivery system. J. Nanoparticle Res. 2014;16:2672. doi: 10.1007/s11051-014-2672-z.", "ArticleIdList": ["10.1007/s11051-014-2672-z"]}, {"Citation": "Hu C., Chiang C., Hong P., Yeh M. Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers. Int. J. Nanomedicine. 2012;7:4861\u20134872. doi: 10.2147/IJN.S34770.", "ArticleIdList": ["10.2147/IJN.S34770", "PMC3441231", "23028215"]}, {"Citation": "Iannelli F., Lombardi R., Milone M.R., Pucci B., De Rienzo S., Budillon A., Bruzzese F. Targeting mevalonate pathway in cancer treatment: Repurposing of statins. Recent Pat. Anticancer. Drug Discov. 2018;13:184\u2013200. doi: 10.2174/1574892812666171129141211.", "ArticleIdList": ["10.2174/1574892812666171129141211", "29189178"]}, {"Citation": "Jardim K.V., Joanitti G.A., Azevedo R.B., Parize A.L. Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chondroitin sulfate nanoparticles. Mater. Sci. Eng. C. 2015;56:294\u2013304. doi: 10.1016/j.msec.2015.06.036.", "ArticleIdList": ["10.1016/j.msec.2015.06.036", "26249593"]}, {"Citation": "Jardim K.V., Siqueira J.L.N., B\u00e1o S.N., Sousa M.H., Parize A.L. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin. Carbohydr. Polym. 2020;227 doi: 10.1016/j.carbpol.2019.115351.", "ArticleIdList": ["10.1016/j.carbpol.2019.115351", "31590861"]}, {"Citation": "Jiang L., Duan H., Ji X., Wang T., Wang Y., Qiu J. Application of a simple desolvation method to increase the formation yield, physical stability and hydrophobic drug encapsulation capacity of chitosan-based nanoparticles. Int. J. Pharm. 2018;545:117\u2013127. doi: 10.1016/j.ijpharm.2018.03.044.", "ArticleIdList": ["10.1016/j.ijpharm.2018.03.044", "29601975"]}, {"Citation": "Jiang L.Q., Wang T.Y., Webster T.J., Duan H.-J., Qiu J.Y., Zhao Z.M., Yin X.X., Zheng C.L. Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport. Int. J. Nanomedicine. 2017;12:6383\u20136398. doi: 10.2147/IJN.S142060.", "ArticleIdList": ["10.2147/IJN.S142060", "PMC5587219", "28919742"]}, {"Citation": "Jiang Y., Yu X., Su C., Zhao L., Shi Y. Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress. Artif. Cells, Nanomedicine, Biotechnol. 2019;47:747\u2013756. doi: 10.1080/21691401.2019.1577876.", "ArticleIdList": ["10.1080/21691401.2019.1577876", "30873872"]}, {"Citation": "Karimi B., Ashrafi M., Shomali T., Yektaseresht A. Therapeutic effect of simvastatin on DMBA-induced breast cancer in mice. Fundam. Clin. Pharmacol. 2019;33:84\u201393. doi: 10.1111/fcp.12397.", "ArticleIdList": ["10.1111/fcp.12397", "29962034"]}, {"Citation": "Kong R., Zhu X., Meteleva E.S., Dushkin A.V., Su W. Physicochemical characteristics of the complexes of simvastatin and atorvastatin calcium with hydroxypropyl-\u03b2-cyclodextrin produced by mechanochemical activation. J. Drug Deliv. Sci. Technol. 2018;46:436\u2013445. doi: 10.1016/j.jddst.2018.05.018.", "ArticleIdList": ["10.1016/j.jddst.2018.05.018"]}, {"Citation": "Kou C.-H., Han J., Han X.-L., Zhuang H.-J., Zhao Z.-M. Preparation and characterization of the Adriamycin-loaded amphiphilic chitosan nanoparticles and their application in the treatment of liver cancer. Oncol. Lett. 2017;14:7833\u20137841. doi: 10.3892/ol.2017.7210.", "ArticleIdList": ["10.3892/ol.2017.7210", "PMC5755166", "29344229"]}, {"Citation": "Li R., Xie Y. Nanodrug delivery systems for targeting the endogenous tumor microenvironment and simultaneously overcoming multidrug resistance properties. J. Control. Release. 2017;251:49\u201367. doi: 10.1016/j.jconrel.2017.02.020.", "ArticleIdList": ["10.1016/j.jconrel.2017.02.020", "28232226"]}, {"Citation": "Li Y.C., Park M.J., Ye S.-K., Kim C.-W., Kim Y.-N. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am. J. Pathol. 2006;168:1107\u20131118. doi: 10.2353/ajpath.2006.050959.", "ArticleIdList": ["10.2353/ajpath.2006.050959", "PMC1606567", "16565487"]}, {"Citation": "Matusewicz L., Podkalicka J., Sikorski F.A. Immunoliposomes with simvastatin as a potential therapeutic in treatment of breast cancer cells overexpressing HER2\u2014an in vitro study. Cancers (Basel) 2018 doi: 10.3390/cancers10110418.", "ArticleIdList": ["10.3390/cancers10110418", "PMC6266203", "30388834"]}, {"Citation": "Meola T.R., Schultz H.B., Peressin K.F., Prestidge C.A. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry. Eur. J. Pharm. Sci. 2020;150 doi: 10.1016/j.ejps.2020.105357.", "ArticleIdList": ["10.1016/j.ejps.2020.105357", "32446169"]}, {"Citation": "Muscella, A., Vetrugno, C., Migoni, D., Biagioni, F., Fanizzi, F.P., Fornai, F., De Pascali, S.A., Marsigliante, S., 2014. Antitumor activity of [Pt(O,O\u2019-acac)(\u03b3-acac)(DMS)] in mouse xenograft model of breast cancer. Cell Death Dis. 5, e1014\u2013e1014. https://doi.org/10.1038/cddis.2013.554", "ArticleIdList": ["PMC4040677", "24457958"]}, {"Citation": "Nirogi R., Mudigonda K., Kandikere V. Chromatography\u2013mass spectrometry methods for the quantitation of statins in biological samples. J. Pharm. Biomed. Anal. 2007;44:379\u2013387. doi: 10.1016/j.jpba.2007.02.008.", "ArticleIdList": ["10.1016/j.jpba.2007.02.008", "17433599"]}, {"Citation": "Oesterle A., Laufs U., Liao J.K. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 2017;120:229\u2013243. doi: 10.1161/CIRCRESAHA.116.308537.", "ArticleIdList": ["10.1161/CIRCRESAHA.116.308537", "PMC5467317", "28057795"]}, {"Citation": "Patil P., Patil V., Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm. 2007;57:111\u2013122. doi: 10.2478/v10007-007-0009-5.", "ArticleIdList": ["10.2478/v10007-007-0009-5", "19839411"]}, {"Citation": "Pranatharthiharan S., Patel M.D., Malshe V.C., Pujari V., Gorakshakar A., Madkaikar M., Ghosh K., Devarajan P.V. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma. Drug Deliv. 2017;24:20\u201329. doi: 10.1080/10717544.2016.1225856.", "ArticleIdList": ["10.1080/10717544.2016.1225856", "28155331"]}, {"Citation": "Qi R., Zhang H., Xu L., Shen W., Chen C., Wang C., Cao Y., Wang Y., van Dongen M.A., He B., Wang S., Liu G., Banaszak Holl M.M., Zhang Q. G5 PAMAM dendrimer versus liposome: A comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin. Nanomedicine Nanotechnology. Biol. Med. 2015;11:1141\u20131151. doi: 10.1016/j.nano.2015.02.011.", "ArticleIdList": ["10.1016/j.nano.2015.02.011", "25791813"]}, {"Citation": "Relja B., Meder F., Wang M., Blaheta R., Henrich D., Marzi I., Lehnert M. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int. J. Oncol. 2011;38:879\u2013885. doi: 10.3892/ijo.2010.892.", "ArticleIdList": ["10.3892/ijo.2010.892", "21206971"]}, {"Citation": "Relja B., Meder F., Wilhelm K., Henrich D., Marzi I., Lehnert M. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int. J. Mol. Med. 2010;26:735\u2013741. doi: 10.3892/ijmm_00000520.", "ArticleIdList": ["10.3892/ijmm_00000520", "20878096"]}, {"Citation": "Rezazadeh M., Parandeh M., Akbari V., Ebrahimi Z., Taheri A. Incorporation of rosuvastatin-loaded chitosan/ chondroitin sulfate nanoparticles into a thermosensitive hydrogel for bone tissue engineering: preparation, characterization, and cellular behavior. Pharm. Dev. Technol. 2019;24:357\u2013367. doi: 10.1080/10837450.2018.1484765.", "ArticleIdList": ["10.1080/10837450.2018.1484765", "29863957"]}, {"Citation": "Ribeiro T.G., Ch\u00e1vez-Fumagalli M.A., Valadares D.G., Fran\u00e7a J.R., Rodrigues L.B., Duarte M.C., Lage P.S., Andrade P.H.R., Lage D.P., Arruda L.V., Ab\u00e1nades D.R., Costa L.E., Martins V.T., Tavares C.A.P., Castilho R.O., Coelho E.A.F., Faraco A.A.G. Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system. Int. J. Nanomedicine. 2014;9:877\u2013890. doi: 10.2147/IJN.S55678.", "ArticleIdList": ["10.2147/IJN.S55678", "PMC3931713", "24627630"]}, {"Citation": "Rizvi, S.Z.H., Shah, F.A., Khan, N., Muhammad, I., Ali, K.H., Ansari, M.M., Din, F. ud, Qureshi, O.S., Kim, K.-W., Choe, Y.-H., Kim, J.-K., Zeb, A., 2019. Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model. Int. J. Pharm. 560, 136\u2013143. https://doi.org/10.1016/j.ijpharm.2019.02.002", "ArticleIdList": ["30753932"]}, {"Citation": "Safwat S., Ishak R.A., Hathout R.M., Mortada N.D. Statins anticancer targeted delivery systems: re-purposing an old molecule. J. Pharm. Pharmacol. 2017;69:613\u2013624. doi: 10.1111/jphp.12707.", "ArticleIdList": ["10.1111/jphp.12707", "28271498"]}, {"Citation": "Sedki M., Khalil I.A., El-Sherbiny I.M. Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer. Artif. Cells, Nanomedicine, Biotechnol. 2018;46:S641\u2013S650. doi: 10.1080/21691401.2018.1505743.", "ArticleIdList": ["10.1080/21691401.2018.1505743", "30295086"]}, {"Citation": "Sharma S., Swetha K.L., Roy A. Chitosan-Chondroitin sulfate based polyelectrolyte complex for effective management of chronic wounds. Int. J. Biol. Macromol. 2019;132:97\u2013108. doi: 10.1016/j.ijbiomac.2019.03.186.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.03.186", "30926509"]}, {"Citation": "Silva T.D., Oliveira M.A., de Oliveira R.B., Vianna-Soares C.D. Development and Validation of a Simple and Fast HPLC Method for Determination of Lovastatin, Pravastatin and Simvastatin. J. Chromatogr. Sci. 2012;50:831\u2013838. doi: 10.1093/chromsci/bms079.", "ArticleIdList": ["10.1093/chromsci/bms079", "22689902"]}, {"Citation": "Soe Z.C., Poudel B.K., Nguyen H.T., Thapa R.K., Ou W., Gautam M., Poudel K., Jin S.G., Jeong J.-H., Ku S.K., Choi H.-G., Yong C.S., Kim J.O. Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells. Asian J. Pharm. Sci. 2019;14:40\u201351. doi: 10.1016/j.ajps.2018.09.004.", "ArticleIdList": ["10.1016/j.ajps.2018.09.004", "PMC7032194", "32104437"]}, {"Citation": "Sun, Y., Ma, W., Yang, Y., He, M., Li, A., Bai, L., Yu, B., Yu, Z., 2019. Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy. Asian J. Pharm. Sci. https://doi.org/10.1016/j.ajps.2019.04.005", "ArticleIdList": ["PMC7032247", "32104485"]}, {"Citation": "Turato C., Balasso A., Carloni V., Tiribelli C., Mastrotto F., Mazzocca A., Pontisso P. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma. J. Control. Release. 2017;268:184\u2013197. doi: 10.1016/j.jconrel.2017.10.027.", "ArticleIdList": ["10.1016/j.jconrel.2017.10.027", "29051062"]}, {"Citation": "Umerska A., Corrigan O.I., Tajber L. Design of chondroitin sulfate-based polyelectrolyte nanoplexes: Formation of nanocarriers with chitosan and a case study of salmon calcitonin. Carbohydr. Polym. 2017;156:276\u2013284. doi: 10.1016/j.carbpol.2016.09.035.", "ArticleIdList": ["10.1016/j.carbpol.2016.09.035", "27842824"]}, {"Citation": "Wang, S.-T., Ho, H.J., Lin, J.-T., Shieh, J.-J., Wu, C.-Y., 2017. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Cell Death Dis. 8, e2626\u2013e2626. https://doi.org/10.1038/cddis.2016.472", "ArticleIdList": ["PMC5386458", "28230855"]}, {"Citation": "Wang X., Wu F., Li G., Zhang N., Song X., Zheng Y., Gong C., Han B., He G. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy. Acta Biomater. 2018;74:414\u2013429. doi: 10.1016/j.actbio.2018.05.030.", "ArticleIdList": ["10.1016/j.actbio.2018.05.030", "29787814"]}, {"Citation": "Wang Y., Wang S., Song R., Cai J., Xu J., Tang X., Li N. Ginger polysaccharides induced cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Int. J. Biol. Macromol. 2019;123:81\u201390. doi: 10.1016/j.ijbiomac.2018.10.169.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.10.169", "30414900"]}, {"Citation": "World health organization, 2018. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Geneva."}, {"Citation": "Wu L., Shan W., Zhang Z., Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv. Drug Deliv. Rev. 2018;124:150\u2013163. doi: 10.1016/j.addr.2017.10.001.", "ArticleIdList": ["10.1016/j.addr.2017.10.001", "28989056"]}, {"Citation": "Yuan N.-Y., Tsai R.-Y., Ho M.-H., Wang D.-M., Lai J.-Y., Hsieh H.-J. Fabrication and characterization of chondroitin sulfate-modified chitosan membranes for biomedical applications. Desalination. 2008;234:166\u2013174. doi: 10.1016/j.desal.2007.09.083.", "ArticleIdList": ["10.1016/j.desal.2007.09.083"]}, {"Citation": "Zhang Y., Huo M., Zhou J., Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Programs Biomed. 2010;99:306\u2013314. doi: 10.1016/j.cmpb.2010.01.007.", "ArticleIdList": ["10.1016/j.cmpb.2010.01.007", "20176408"]}, {"Citation": "Zhang, Y., Liu, Y., Luo, Y., Yao, Q., Zhong, Y., Tian, B., Tang, X., 2016. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. Drug Deliv. 23, 1902\u20131911. https://doi.org/10717544.2014.960982", "ArticleIdList": ["25268150"]}, {"Citation": "Zhang Z., Bu H., Gao Z., Huang Y., Gao F., Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int. J. Pharm. 2010;394:147\u2013153. doi: 10.1016/j.ijpharm.2010.04.039.", "ArticleIdList": ["10.1016/j.ijpharm.2010.04.039", "20435111"]}, {"Citation": "Zhao, Z., Ukidve, A., Krishnan, V., Mitragotri, S., 2019. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv. Drug Deliv. Rev. https://doi.org/10.1016/j.addr.2019.01.002", "ArticleIdList": ["30639257"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "6", "Day": "12"}, {"Year": "2020", "Month": "11", "Day": "23"}, {"Year": "2021", "Month": "1", "Day": "11", "Hour": "5", "Minute": "35"}, {"Year": "2021", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "11", "Day": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33424274", "PMC7783227", "10.1016/j.jsps.2020.11.012", "S1319-0164(20)30273-5"]}}], "PubmedBookArticle": []}